Sun Pharma Q2 Preview: Profit may rise by 19%, R&D spends to impact margins

Analysts expect Sun Pharma to register double digit growth in the topline and bottomline driven by specialty sales

Subscribe To Our Free Newsletter

All News, Business Standard All News